Hey SP - Search Results

1

Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein Inhibitors.

Hey SP, Franklin JM, Avorn J, Kesselheim AS. Hey SP, et al. Circ Cardiovasc Qual Outcomes. 2017 Jun;10(6):e003121. doi: 10.1161/CIRCOUTCOMES.116.003121. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28611186 Review.

2

Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib.

Carlisle B, Demko N, Freeman G, Hakala A, MacKinnon N, Ramsay T, Hey S, London AJ, Kimmelman J. Carlisle B, et al. J Natl Cancer Inst. 2015 Nov 7;108(1):djv292. doi: 10.1093/jnci/djv292. Print 2016 Jan. J Natl Cancer Inst. 2015. PMID: 26547927 Free PMC article. Review.

3

An Uninformative Truth: The Logic of Amarin's Off-Label Promotion.

Hey SP, Kesselheim AS. Hey SP, et al. PLoS Med. 2016 Mar 15;13(3):e1001978. doi: 10.1371/journal.pmed.1001978. eCollection 2016 Mar. PLoS Med. 2016. PMID: 26978686 Free PMC article.

4

The FDA, Juno Therapeutics, and the ethical imperative of transparency.

Hey SP, Kesselheim AS. Hey SP, et al. BMJ. 2016 Aug 15;354:i4435. doi: 10.1136/bmj.i4435. BMJ. 2016. PMID: 27526698 No abstract available.

5

The Challenges of Validating in Precision Medicine: The Case of Excision Repair Cross-Complement Group 1 Diagnostic Testing.

Barsanti-Innes B, Hey SP, Kimmelman J. Barsanti-Innes B, et al. Among authors: hey sp. Oncologist. 2017 Jan;22(1):89-96. doi: 10.1634/theoncologist.2016-0188. Epub 2016 Oct 24. Oncologist. 2017. PMID: 28126916 Free PMC article.

6

Ethical Challenges in Biomarker-Driven Drug Development.

Hey SP. Hey SP. Clin Pharmacol Ther. 2018 Jan;103(1):23-25. doi: 10.1002/cpt.862. Epub 2017 Sep 25. Clin Pharmacol Ther. 2018. PMID: 28944956

7

Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.

Nicholls SG, Carroll K, Brehaut J, Weijer C, Hey SP, Goldstein CE, Zwarenstein M, Graham ID, McKenzie JE, McIntyre L, Jairath V, Campbell MK, Grimshaw JM, Fergusson DA, Taljaard M. Nicholls SG, et al. Among authors: hey sp. BMC Med Ethics. 2018 Nov 20;19(1):90. doi: 10.1186/s12910-018-0332-z. BMC Med Ethics. 2018. PMID: 30458809 Free PMC article.

8

A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology.

Haslam A, Hey SP, Gill J, Prasad V. Haslam A, et al. Among authors: hey sp. Eur J Cancer. 2019 Jan;106:196-211. doi: 10.1016/j.ejca.2018.11.012. Epub 2018 Dec 5. Eur J Cancer. 2019. PMID: 30528804

9

A Comparison of Response Patterns for Progression-Free Survival and Overall Survival Following Treatment for Cancer With PD-1 Inhibitors: A Meta-analysis of Correlation and Differences in Effect Sizes.

Gyawali B, Hey SP, Kesselheim AS. Gyawali B, et al. Among authors: hey sp. JAMA Netw Open. 2018 Jun 1;1(2):e180416. doi: 10.1001/jamanetworkopen.2018.0416. JAMA Netw Open. 2018. PMID: 30646078 Free PMC article.

10

Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis.

D'Andrea E, Hey SP, Ramirez CL, Kesselheim AS. D'Andrea E, et al. Among authors: hey sp. JAMA Netw Open. 2019 Apr 5;2(4):e192224. doi: 10.1001/jamanetworkopen.2019.2224. JAMA Netw Open. 2019. PMID: 30977858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results